Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a history of exacerbations. Daliresp is also referred to by its drug name, Roflumilast.

Daliresp is a phosphodiesterase inhibitor. Daliresp is believed to work by decreasing the amount of certain molecules that cause inflammation.

How do I take it?
Prescribing information states that Daliresp is generally taken once daily.

Daliresp comes in tablet form.

Side effects
The FDA-approved label for Daliresp lists common side effects including dizzi... read more

Daliresp (Roflumilast) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in